P3 Research secures investment from Genesis Capital to accelerate expansion
- Written by PR Newswire
- P3 is a leading New Zealand clinical trial site network founded in 1998
- With sites in seven locations throughout New Zealand, P3's clients range from large multi-nationals to small biotechs globally
- Genesis Capital has become the major shareholder of the clinical trials group alongside existing shareholders
WELLINGTON, New Zealand, Dec. 22, 2022 /PRN...